Human minor histocompatibility antigens

Current Opinion in Immunology

Volumn 8, Issue 1, 1996, Pages 75-81

  Goulmy, Els ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MINOR HISTOCOMPATIBILITY ANTIGEN;

BONE MARROW; BONE MARROW TRANSPLANTATION; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MINOR HISTOCOMPATIBILITY COMPLEX; REVIEW; T LYMPHOCYTE;

EID: 0029866282     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(96)80108-7     Document Type: Article

References (77)

1. Snell GD: Methods for the study of hisocompatiblibity genes. J Genet 1948, 49:87-103.
2. Counce S, Smith P, Barter R, Snell GD: Strong and weak histocompatibility fine differences in mice and their role in the rejection of homografts of tumors and skin. Ann Surg 1956, 144:198-204.
3. Thomas ED, Storb R, Clift RA, Fefer A, Johnson FC, Newman PE, Cerner KG, Glucksberg H, Buckner CD: Bone marrow transplantation. N Eng J Med 1975, 292:832-843.
4. Goulmy E, Termijtelen A, Bradley BA, Van Rood JJ: Alloimmunity to human H-Y. Lancet 1976, 2:1206.
5. Goulmy E, Termijtelen A, Bradley BA, Van Rood JJ: Y-antigen killing by T cells of women is restricted by HLA. Nature 1977, 266:544-545.
6. Goulmy E: Minor histocompatibility antigens in man and their role in transplantation. In Transplantation Reviews, vol 2. Edited by Morris PJ, Tilney NL. Philadelphia: WB Saunders Company; 1988:2:29-53.
7. De Bueger M, Goulmy E: Human minor histocompatibility antigens. Transplant Immunol 1993, 1:28-38.
8. Schreuder G, Pool J, Blokland E, Van Els C, Bakker A, Van Rood JJ, Goulmy E: A genetic analysis of human minor histocompatibility antigens demonstrates Mendellan segregation independent of HLA. Immunogenetics 1993, 38:98-105.
9. Loveland BE, Fischer Lindahl K: The definition and expression of minor histocompatibility antigens. In Antigen Processing and Recognition. Edited by McCluskey J. Boca Raton, Florida: CRC Press Inc; 1991:173-192.
10. Graft RJ, Bailey DW. The non H-2 histocompatibility loci and their antigens. Transplant Rev 1973, 15:26-49.
11. Rammensee H-G, Klein J: Polymorphism of minor Histocompatibility genes in wild mice. Immunogenetics 1983, 17: 637-647.
12. Storb R, Deeg H, Whitehead HJ, Appelbaum F, Baeatty P, Bensiger W, Buckner CD, Clift R, Doney K, Farewell V et al.: Methotrexate and cyclosphorine compared with cyclosporine alone for prophylaxis of acute graft-versus-host-disease after marrow transplantation for leukemia. N Engl J Med 1986, 314:829-835.
13. Marijt EAF, Veenhof WFJ, Goulmy E, Kluck PMC, Brand A, Willemze R, Van Rood JJ, Falken burg JHF: Multiple minor histocompatibility antigen disparities between a recipient and four HLA-identical potential sibling donors for bone marrow transplantation. Hum Immunol 1993, 37:221-228.
14. Goulmy E, Schipper R, Pool J, Blokland E, Falekenburg JHF, Vossen J, Gratwohl A, Vogelslang GB, Van Houwelingen HC, Van Rood JJ: Mismatches of minor histocompatibility antigen between HLA-identical donor snad recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 1996, 334:281-285.
15. Roopenian DC, Davis AP, Christanson GJ, Mobraaten LE: The functional basis of minor histocompatibility loci. J Immunol 1993, 151:4595-4605.
16. Den Haan JMM, Sherman NE, Blokland E, Huczko E, Koning F, Drijfhout JW, Skipper J, Shabanowitz J, Hunt DF, Engelhard VH, Goulmy E. Identification of graft-versus-host disease associated human minor histocompatibility antigen. Science 1995, 268:1478-1480. First identification of a classic minor histocompatibility antigen.
17. Chen Y, Sidney J, Southwood S, Cox AL, Sakaguchi K, Henderson RA, Appella E, Unt DF, Sette A, Engelhard VH: Naturally processed peptides long than nine amino acid residues bind to the class I molecule HLA-A2.1. With high affinity and in different confirmations. J Immunol 1994, 152:2874-2881.
18. Ruppert J, Sidney J, Celis E, Kubo R, Grey HM, Sette A: Prominant role of secondary anchor residue in peptide binding to HLA-A2.1 molecules. Cell 1993, 74:929-937.
19. Falk K, Rötzschke O, Stevanovic S, Jung G, Rammensee H-G: Allele-sppecific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991, 351:290-296.
20. Chen W, Khilko S, Fecondo J, Margulies DH, McCluskey J: Determinant selection of major histocompatibility complex class I-restricted antigenic peptides Is explained by class I peptide affinity and is strongly influenced by nondominant anchor residues. J Exp Med 1994, 180:1471-1483
21. Barber LD, Parham P: The essence of epitopes. J Exp Med 1994, 180:1191-1194.
22. Goulmy E, Pool J, Van den Elsen PJ: Interindividual conservation of T cell receptor β chain variable regions by minor histocompatibility antigen specific HLA-A*0201 restricted cytotoxic T cell clones. Blood 1995, 85:2478-2481.
23. Van Els C, D'Amaro J, Pod J, Bakker A, Van den Elsen PJ, Van Rood JJ, Goulmy E: Immunogenetics of human minor Histocompailbility antigens: their polymorphism and immunodominance. Immunogenetics 1992, 35:161-165.
24. Dietrich PY, Caignard A, Lim A, Chung V, Pico JL, Pannetier C, Kourilsky P, Hercent T, Even H, Triebel F: In vivo T cell clonal amplification at time of acute graft-versus-host-disease. Blood 1994, 84:2815-2820.
25. Gaschet J, Denis C, Milpied N, Hallet M-M, Romagné F, Necker A, Vivien R, David-Ameline J, Davodeau F, Bonneville M, Vié H: Alterations of T cell repertoire after bone marrow transplantation: characterization of over-represented subsets. Bone Marrow Transplant 1995, 16:427-435. Characterization of chronic GVHD related T-cell clone with specific TCR Vβ usage and anti-host T-cell activity.
26. Ferrara JLM: Cytokine deregulation as a mechanism of graft-versus-host disease. Curr Opin Immunol 1993, 5:794-799.
27. Cohen J: Cytokines as mediators of GvHD. Bone Marrow Transplant 1988, 3:193-197.
28. Jadus MR, Wepsic HT: The role of cytokines in graft-versus-host reactions and disease. Bone Marrow Transplant 1992, 10:1-14.
29. De Bueger M, Bakker A, Van Rood JJ, Van der Woude F, Goulmy E: Tissue distribution of human minor histocompatibility antigens ubiquitous versus restricted tissue distribtuion indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J Immunol 1992, 149:1788-1794.
30. Tanaka J, Imamura M, Kasai M, Sakurada K, Miyazaki T: Cytokine gene expression after allogeneic bone marrow transplantation. Leuk Lymphoma 1995, 16:413-418.
31. Abhyankar S, Gilliland DG, Ferrara JLM: Interleukin 1 is a critical effector molecule during cytokine dysregulation in graft versus host disease to minor histocompatibilty antigens, Transplantation 1993, 56:1518-1523.
32. De Bueger M, Bakker A, Van Rood JJ, Van der Woude F, Goulmy E: Tissue distribution of human minor histocompatibility antigens ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J Immunol 1992, 149:1788-1794.
33. Van Lochern EG, Van de Keur M, Mommaas M, De Dast GC, Goulmy E: Expression of cytotoxic T cell defined minor histocompatibility antigens on human peripheral blood defritic cells and skin derived Langerhans cells. Transplant Immunol, 1996, in press.
34. Goulmy E, Pool J, Van Lochem E, Völker-Dieben H: The role of human minor histocompatibility antigens in graft failure: a mini-review. Eye 1995, 9:180-184.
35. Niederwieser D, Grassegger A, Anböck J, Herold M, Naubaur D, Rosenmayr A, Gächter A, Nussbaumer W, Gaggi S, Ritter M, Huber C: Correlation of minor histocompatibility antigen specific cytotoxic T lymphocytes with graft-versus-host-disease status and analyses of tissue distribution of their target antigens. Blood 1993, 81:2200-2208.
36. Beck Y, Sekimata M, Nakayama S, Müller GA, Yamamoto J, Nagao T, Uchida H, Akyama N, Kariyone A, Takiguchi M: Expression of human minor histocompatibillty antigen on cultured kidney cells. Eur J Immunol 1993, 23:467-472.
37. Yard BA, Koumans-Coutinho M, Reternick T, Van den Elsen P, Paape ME, Bruyn JA, Van Es LA, Daha MR, Van der Woude FJ: Analysis of T cell lines from rejection renal allograft Kidney Int 1993, 43:S133-S138.
38. Poindexter NJ, Steward NS, Shenoy S, Jendrisak MD, Flye MW, Howard TK, Mohanakumar T: Cytolytic T lymphocytes from human renal allograft biopsies are tissue specific. Human Immunol 1995, 44:43-49. MHC class I restricted CTL clones from biopsy infiltrating cell lines are shown to recognize kidney specific antigens.
39. Yard BA, Claas, FHJ, Paape ME, Bruijn JA, Daha MR, Van Es LA, Van der Woude FJ: Recognition of a tissue-specific polymorphism by graft infiltrating T cell clones isolated from a renal allografting with acute rejection. Nephrol Dial Transplant 1994, 9:805-810.
40. Poindexter NJ, Nazruddin B, Mc Court DW, Mohanakumar T: Isolation of a kidney specific peptide recognized by alloreactive HLA-A3 restricted human CTL J Immunol 1995, 154:3880-3887. First isolation and sequencing of a kidney tissue specific T-cell epitope.
41. Goulmy E: Lifting a trip of the veil of human minor histocompatibility antigens. In The Nato ASI Series: Gene Technology in Analysis of Malignant and Inherited Human Diseases Related to Development, 1996: in press.
42. Van Els CACM, Bakker A, Zwinderman AH, Zwaan FE, Van Rood JJ, Goulmy E: Effector mechanisms In GvHD in response to minor histocompatibility antigens. II: Evidence for a possible involvement of proliferative T cells. Transplantation 1990, 50:67-71.
43. Nierle T, Bunjes D, Arnold R, Heimpel H, Theobald M: Quantitative assessment of posttransplant host specific interleukin-2 secreting T helper cell precursors in patients with and without acute graft-versus-host disease after allogeneic HLA-identical sibling bone marrow transplantation. Blood 1993, 81:841-848.
44. Theobald M, Nierle T, Bunjes D, Arnold R, Heimpel H: Host specific interleukin-2 secretting donor T cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings. N Engl J Med 1992, 327:1613-1617.
45. Schwarer AP, Jiang JZ, Barrett JM, Batchelor JR, Goldman JM, Lechler RI: Helper T-lymohocyte precursor (HTLp) frequency predicts the occurrence and severity of acute GvHD and survival after allogeneic BMT in both recipients of genotypically HLA-identical sibling (SIB) and phenotypically HLA-matched unrelated donor (MUD) marrow. Lancet 1993, 341:203-205.
46. + T cell subsets. Blood 1993, 82:298-306.
47. Falkenburg F, Goselink H, Van der Harst D, Van Luxemburg-Heijs SAP, Kooy-Winkelaar YMC, Faber LM, De Kroon J, Brand A, Fibbe WE, Willemze R, Goulmy E: Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibillty antigen-specific cytotoxic T lymphocytes. J Exp Med 1991, 174:27-33.
48. Van der Harst D, Goulmy E, Falkenburg JHF: Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T cell clones. Blood 1994, 83:1060-1066.
49. Van Lochem E, De Gast B, Goulmy E: In vitro separation of host specific graft-versus-host and graft-versus-leukemia cytotoxic T cell activities. Bone Marrow Transplant 1992, 10:181-183.
50. Hoffman T, Theobald M, Bunjes D, Weiss M, Heimpel H, Heit W: Frequency of bone marrow T cells responding to HLA identical non-leukemic stimulator cells. Bone Marrow Transplant 1993, 12:1-8.
51. Datta AR, Barrett AJ, Jiang YZ, Guimaraes A, Mavroudis DA, Van Rhee F, Gordon AA, Madrigal A: Distinct T cell populations distinguish chronic myeolold leukaemia cells from lymphocytes in the same individual: a model for separating GvHD from GvL reactions. Bone Marrow Transplant 1994, 14:517-524.
52. De Plasn E, Lurquin C, Van El A: Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum-antigen P91A and identification of the tum-mutation. Proc Natl Acad Sci USA 1988, 85:2274-2278.
53. Loveland BE, Fischer Lindahl K: Definition and expression of minor histocompatibility antigens. In Antigen Processing and Presentation. Edited by McCluskey J. London: CRC Press; 1991:173-192.
54. Demotz S, Grey HM, Appella E, Sette A: Characterization of a naturally processed MHC class II restricted T cell determinant of hen egg Iysozyme. Nature 1989, 342:682-684.
55. Rötzschke O, Falk K, Deres H, Schild H, Norda M, Metzger J, Jung G, Rammensee H-G; Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 1990, 348:252-254.
56. Rötzschke O, Falk K, Wallny H-J, Faath S, Rammensee HG: Characterization of naturally occurring minor histocompatibility peptides including H-4 and H-Y. Science 1989, 249:283-287.
57. Falk K, Rötzschke O, Rammensee H-G: Cellular peptide composition governed by major histocompatibility complex class I molecules. Nature 1990, 348:248-251.
58. Sekimata M, Griem P, Egawa K, Rammensee H-G, Takiguchi M: Isolation of human minor histocompatibility peptides. Int Immunol 1992, 4:301-304.
59. De Bueger M, Verreck F, Blokland E, Drijfhout J-W, Amons R, Koning F, Goulmy E: Isolation of an HLA-A2.1 extracted human minor histocompatibility peptide. Eur J Immunol 1993, 23:614-618.
60. Hunt DF, Henderson RA, Shabanowicz J, Sakaguchi K, Michel H, Sevilir N, Cox A, Appella E, Engelhard VH: Characterization of peptides bound to class I MHC molecule HLA-A2.1 by mass spectrometry. Science 1992, 255:1261-1263.
61. Wang W, Meadows LR, Den Haan JMM, Sherman NE, Chen Y, Blokland E, Shabanowitz J, Agulnik AI, Hendrickson RC, Bishop CE et al.:Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science 1995, 269:1588-1590. First identification of the human male specific mHag H-Y.
62. Titus MA: Myosins. Curr Opin Cell Biol 1993, 5:77-81.
63. Scott DN, Ehrmann IE, Ellis PS, Bishop CE, Agulnik Al, Simpson E, Mitchell MJ: Identification of a mouse male specific transplantation antigen H-Y. Nature 1995, 376:695-698. First identification of the murine male specific mHag H-Y.
64. Agulnik AI, Mitchell MJ, Lerner JC, Woods DR, Bishop CE: A mouse Y chromosome gene encoded by a region essential for spermatogenesis and expression of male specific minor histocompatibillty antigens. Human Mol Genet 1994, 3:873-878.
65. Voogt PJ, Fibbe WE, Marijt WAF, Goulmy E, Veenhool WFJ, Hamilton M, Brand A, Zwaan FE, Willemze R, Van Rood JJ, Falkenburg JHF: Rejection of bone marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens. Lancet 1990, 335:131-134.
66. Zier KS, Elkins WL, Pierson GR, Leo MM: The use of cytotoxic Tcell lines to detect the segregation of a human minor alloantigen within families. Hum Immunol 1983, 7:117-129.
67. Goulmy E, Hamilton JD, Bradley BA: Anti-self HLA may be clonally expressed. J Exp Med 1979, 149:545-550.
68. Irlé C, Beatty PG, Mickleson E, Donnall THomas E, Hansen JA: Alloreactive T cell responses between HLA-identlcal siblings. Detection of anti-tumor histocompatiblitiy T-cell clones induced in vivo. Transplantation 1995, 40329-333.
69. Beck Y, Sekimata M, Nakayama S, Müller CA, Yamamoto J, Nagao T, Uchida H, Akiyama N, Kariyone A, Takiguchi M: Isolation of human minor histocompatibitlity peptides from cultured kidney cells. Trans Proc 1993, 25:162-166.
70. Yamamoto J, Kariyone A, Akiyama N, Kano K, Takiguchi M: Presentation of human minor histocompatibility antigens by HLA-B35 and HLA-B38 molecules. Proc Natl Acad Sci USA 1990, 87:2583-2587.
71. Vinci G, Masset M, Semana G, Vernant J-P: A human minor histocompatibility antigen which appears to segregate with the major histocompatibility complex. Transplantation 1994, 58:361-367.
72. + T cells with genuine class I restriction. Eur J Immunol 1992, 22:875-878.
73. Mickelson EM, Beatty PG, Storb, Hansen JA: Immune responses in an untransfected patient with aplastic anemia: analysis of cytolytic and proliferative T cell clones. Hum Immunol 1984, 10:189-201.
74. Tilkin AF, Bagot M, Kayibanda M, Vernant JP, Levy JP: A human autoreactive T cell line specific for minor histocompatibility antigen(s) isolated from a bone marrow-grafted patient Transplantation 1986, 137:3772-3276.
75. Nishimura M, Akaza T, Mitomi Y, Nieda M, Minami M, Juj T: Establishment of human minor histocompatibility antigen-specific cytotoxic T cell clones restricted by HLA-DR9. Transplantation 1993, 44:1181-1186.
76. + minor histocompatibility antigen-specific cytotoxic T lymphocytes. J Clin Invest 1995, 96:877-883.
77. Reinsmoen N, Kersey KJ, Bach FH: Detection of HLA restricted anti-tumor histocompatibility antigen(s) reactive cells from skin versus GVH lesions. Hum Immunol 1984, 11:249-257.